Medical Device News Magazine, in addition to offering a comprehensive view of the latest medical device news and industry information, publishes news on topics such as artificial intelligence (AI), medical manufacturing, other services, and more.
“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”
The launch incorporates learnings from a pilot program with HCA Healthcare (NYSE: HCA), one of the nation's leading healthcare providers. As part of the pilot, ED physicians in four HCA Healthcare hospitals utilized Augmedix Go to automate medical documentation, with the product instantaneously drafting their medical notes from patient visits.
“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”
O-GENESIS Graft Delivery System (a complete bone graft delivery system) is designed to deliver allograft, autograft or synthetic bone graft to orthopedic surgical sites. The company is also introducing the AlloQuent™ Structural Allograft Q-Pack®
Biocartis notes the test was developed by Biocartis’ partner Immunexpress Pty Ltd (‘Immunexpress’), a Seattle-based (US) molecular diagnostics company, and is now being released as part of Biocartis’ exclusive commercialization2 of SeptiCyte® RAPID on Idylla™ in Europe.
The company designs and manufactures hospital-grade mechatronic systems that are user friendly and provide a special type of Focused Multivector Ultraviolet (FMUV) light technology, for the purpose of disinfection in 90 seconds.
The RS6 Laser Scanner scans up to 1.2 million points/sec with a scan rate of 300 Hz. The RS6 also has a wider laser stripe of 150 mm at mid-range and a visual guide that provides real-time feedback for stand-off distance.
AOTI notes the addition of a new larger extremity-chamber to the company's peripheral vascular disease-focused product line, allows for the application of TWO2 treatments for many more patients suffering from costly nonhealing chronic wounds.
Rhinomed notes this new high-yielding nasal swab that can collect samples from the nose to test for the presence of upper respiratory tract diseases, including influenza and coronavirus strains.
By using this website you agree to accept Medical Device News Magazine Privacy Policy
